↑Tang KM, Wang GR, Lu P, Karas RH, Aronovitz M, Heximer SP, Kaltenbronn KM, Blumer KJ, Siderovski DP, Zhu Y, Mendelsohn ME, Tang M, Wang G (December 2003). „Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure”. Nat. Med.9 (12): 1506–12. DOI:10.1038/nm958. PMID14608379.
↑Salim S, Sinnarajah S, Kehrl JH, Dessauer CW (May 2003). „Identification of RGS2 and type V adenylyl cyclase interaction sites”. J. Biol. Chem.278 (18): 15842–9. DOI:10.1074/jbc.M210663200. PMID12604604.
Literatura
Siderovski DP, Blum S, Forsdyke RE, Forsdyke DR (1991). „A set of human putative lymphocyte G0/G1 switch genes includes genes homologous to rodent cytokine and zinc finger protein-encoding genes.”. DNA Cell Biol.9 (8): 579–87. DOI:10.1089/dna.1990.9.579. PMID1702972.
Wu HK, Heng HH, Shi XM, et al. (1995). „Differential expression of a basic helix-loop-helix phosphoprotein gene, G0S8, in acute leukemia and localization to human chromosome 1q31.”. Leukemia9 (8): 1291–8. PMID7643615.
Druey KM, Blumer KJ, Kang VH, Kehrl JH (1996). „Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family.”. Nature379 (6567): 742–6. DOI:10.1038/379742a0. PMID8602223.
Siderovski DP, Hessel A, Chung S, et al. (1996). „A new family of regulators of G-protein-coupled receptors?”. Curr. Biol.6 (2): 211–2. DOI:10.1016/S0960-9822(02)00454-2. PMID8673468.
Heximer SP, Cristillo AD, Forsdyke DR (1997). „Comparison of mRNA expression of two regulators of G-protein signaling, RGS1/BL34/1R20 and RGS2/G0S8, in cultured human blood mononuclear cells.”. DNA Cell Biol.16 (5): 589–98. DOI:10.1089/dna.1997.16.589. PMID9174164.
Tseng CC, Zhang XY (1998). „Role of regulator of G protein signaling in desensitization of the glucose-dependent insulinotropic peptide receptor.”. Endocrinology139 (11): 4470–5. DOI:10.1210/en.139.11.4470. PMID9794454.
Beadling C, Druey KM, Richter G, et al. (1999). „Regulators of G protein signaling exhibit distinct patterns of gene expression and target G protein specificity in human lymphocytes.”. J. Immunol.162 (5): 2677–82. PMID10072511.
Popov SG, Krishna UM, Falck JR, Wilkie TM (2000). „Ca2+/Calmodulin reverses phosphatidylinositol 3,4, 5-trisphosphate-dependent inhibition of regulators of G protein-signaling GTPase-activating protein activity.”. J. Biol. Chem.275 (25): 18962–8. DOI:10.1074/jbc.M001128200. PMID10747990.
Chatterjee TK, Fisher RA (2000). „Cytoplasmic, nuclear, and golgi localization of RGS proteins. Evidence for N-terminal and RGS domain sequences as intracellular targeting motifs.”. J. Biol. Chem.275 (31): 24013–21. DOI:10.1074/jbc.M002082200. PMID10791963.
Cunningham ML, Waldo GL, Hollinger S, et al. (2001). „Protein kinase C phosphorylates RGS2 and modulates its capacity for negative regulation of Galpha 11 signaling.”. J. Biol. Chem.276 (8): 5438–44. DOI:10.1074/jbc.M007699200. PMID11063746.
Heximer SP, Lim H, Bernard JL, Blumer KJ (2001). „Mechanisms governing subcellular localization and function of human RGS2.”. J. Biol. Chem.276 (17): 14195–203. DOI:10.1074/jbc.M009942200. PMID11278586.
Mittmann C, Schüler C, Chung CH, et al. (2001). „Evidence for a short form of RGS3 preferentially expressed in the human heart.”. Naunyn Schmiedebergs Arch. Pharmacol.363 (4): 456–63. DOI:10.1007/s002100000376. PMID11330340.